Health Policy and Management News
Meier wins ‘Outstanding Alumnus’ award from Columbia
August 22, 2017
Dr. Benjamin Meier, adjunct assistant professor in health policy and management, has received an outstanding alumnus award from Columbia University’s Mailman School of Public Health.
Study finds widening disparities in infant mortality and life expectancy between Appalachia, rest of US
August 8, 2017
A new study co-authored by Dr. Rebecca Slifkin confirms a widening gap in health equity between Appalachia and the rest of the United States. Slifkin and colleagues call for policy changes and financial support to help people who live in economically depressed regions. Photo courtesy of Virginia State Parks.
School leaders welcome new faculty members, announce promotions
July 27, 2017
This list includes new faculty members and faculty promotions for the period between December 2016 and June 2017.
Alumnus Seunik completes year in inaugural cohort of Schwarzman Scholars
July 10, 2017
Health policy and management alumnus Max Seunik has completed graduate work in the first cohort of Schwartzman Scholars at China’s Tsinghua University, where he studied global development and public policy.
US aid to combat malaria in Africa associated with reduced risk of childhood mortality
June 16, 2017
Funding from the U.S. President’s Malaria Initiative (PMI) in 19 sub-Saharan African countries was associated with a 16 percent reduction in the annual risk of children dying before age five, according to a new study by health policy and management researchers Aleksandra Jakubowksi and Dr. Harsha Thirumurthy.
‘Look deeper and go local’ when crafting public health messages in turbulent political environments
June 13, 2017
In light of ongoing political and resource shifts taking place in health care, Gene Matthews, JD, of the North Carolina Institute for Public Health, shared tips for crafting richer public health messages with the potential to impact policy makers and communities across political lines.
Advanced cancer patients survive longer when given chance to report symptoms during treatment
June 8, 2017
Patients who receive treatment for advanced cancers commonly experience symptoms that go unreported to and undetected by clinicians. In an effort to improve patient survival and quality of life, a new study led by Dr. Ethan Basch examines the impact of patients having the opportunity to report symptoms electronically as they occur.
Drug rebates: Who pays, who profits, how can we make drug prices more equitable?
June 5, 2017
A new study led by Dr. Stacie Dusetzina examines how drug rebates result in disparities in medication costs. She and colleagues show that rebates may increase costs for Medicare Part D beneficiaries and the federal Medicare program, while decreasing costs for drug manufacturers and Part D (drug) insurance plans.
New study investigates perceptions, ethics of treatment interruptions in HIV cure research
June 2, 2017
Two faculty members from the Gillings School investigated how stakeholders respond to the concept of using analytical treatment interruptions to test the efficacy of potential HIV cure research strategies in the absence of antiretroviral therapy.
Drug company payments associated with physicians’ prescribing choices for cancer drugs
June 2, 2017
Gillings School investigators found an association between physicians receiving payments from pharmaceutical companies for meals, talks and travel and those physicians prescribing the companies’ drugs for two types of cancer. The findings were presented at the annual meeting of the American Society of Clinical Oncology.